The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation.

MLA

Piayda, Kerstin, et al. “The Role of Matrix Metalloproteinase-2 and Galectin-3 as Predictive Biomarkers for All-Cause Mortality in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation.” Biomarkers, vol. 29, no. 4, June 2024, pp. 205–10. EBSCOhost, https://doi.org/10.1080/1354750X.2024.2341409.

APA

Piayda, K., Heilemann, J. T., Keranov, S., Schulz, L., Arsalan, M., Liebetrau, C., Kim, W.-K., Hofmann, F. J., Bauer, P., Voss, S., Troidl, C., Sossalla, S. T., Hamm, C. W., Nef, H. M., & Dörr, O. (2024). The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation. Biomarkers, 29(4), 205–210. https://doi.org/10.1080/1354750X.2024.2341409

Chicago

Piayda, Kerstin, Julian Tim Heilemann, Stanislav Keranov, Luisa Schulz, Mani Arsalan, Christoph Liebetrau, Won-Keun Kim, et al. 2024. “The Role of Matrix Metalloproteinase-2 and Galectin-3 as Predictive Biomarkers for All-Cause Mortality in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation.” Biomarkers 29 (4): 205–10. doi:10.1080/1354750X.2024.2341409.